Improving drug delivery for chronic pain in minority veterans
Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain
This study is working on new ways to help veterans with chronic pain, like osteoarthritis, by using sound waves to deliver medicine that can relieve pain without the risks of addiction, and we want to make sure these solutions fit their specific needs.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Zetroz Systems, LLC NIH-funded |
| Lab location | 1 site (Trumbull, United States) |
| Project ID | NIH-11051818 on NIH RePORTER |
What this research studies
This research focuses on developing and optimizing ultrasonic drug delivery technologies specifically for underserved minority veterans suffering from chronic pain, particularly osteoarthritis. The project aims to address the opioid crisis by providing alternative pain management solutions that are less addictive. By utilizing advanced drug delivery methods, the research seeks to enhance the effectiveness of pain relief while minimizing side effects. The study will involve collaboration with veterans to ensure that the solutions developed are tailored to their unique needs and circumstances.
Who could benefit from this research
Good fit: Ideal candidates for this research are minority veterans experiencing chronic pain, particularly those with osteoarthritis.
Not a fit: Patients who do not have chronic pain or are not part of the minority veteran population may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide veterans with safer and more effective pain management options, reducing reliance on opioids.
How similar studies have performed: While the approach of ultrasonic drug delivery is innovative, similar technologies have shown promise in other patient populations, indicating potential for success in this context.
Where this research is happening
Trumbull, United States
- Zetroz Systems, LLC — Trumbull, United States (Active)
Researchers
- Principal investigator: Lewis, George Kenneth — Zetroz Systems, LLC
- Study coordinator: Lewis, George Kenneth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.